Skip to main content
. 2019 Jun 17;4(3):e000498. doi: 10.1136/esmoopen-2019-000498

Figure 1.

Figure 1

Molecular testing parallel algorithm without next generation sequencing (adapted from Kerr and López-Ríos17). ALK, anaplastic lymphoma kinase; EGFR, epidermal growth factor receptor; FISH, fluorescence in situ hybridisation; ICI, immune checkpoint inhibitor; MDT, multidisciplinary team; NSCLC, non-small cell lung cancer; PD-1, programmed cell death protein 1; PD-L1, programmed death-ligand 1; TKI, tyrosine kinase inhibitor